Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 5/20 | 0.69 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | HTR2B | P41595 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | HTR7 | P34969 | 1/20 | 0.40 |
| ▸ | HTR6 | P50406 | 1/20 | 0.39 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.38 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.38 |
| ▸ | TAS1R2 | Q8TE23 | 2/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1128139 | 0.98 | HTR2C (0.67) | HTR2CHTR2AHTR2BLMNAGAA | |
| SCHEMBL30603834 | 0.98 | HTR2C (0.67) | HTR2CHTR2AHTR2BLMNAGAA | |
| SCHEMBL16956125 | 0.91 | HTR2C (0.74) | HTR2CHTR2AHTR2BHTR6TRPA1 | |
| SCHEMBL16568453 | 0.91 | HTR2C (0.59) | HTR2CHTR2AHTR2BLMNAGAA | |
| SCHEMBL31240954 | 0.86 | HTR2C (0.52) | HTR2CHTR1AHTR7HTR6PTGS2 | |
| SCHEMBL6390262 | 0.84 | HTR2C (0.50) | HTR2CLMNAGAAALOX12HTR1A | |
| SCHEMBL8115742 | 0.84 | HTR2C (0.51) | HTR2CHTR2AHTR2BLMNAGAA | |
| SCHEMBL43079 | 0.82 | HTR2C (0.67) | HTR2CHTR2AHTR2BPTGS2 | |
| SCHEMBL31469392 | 0.82 | HTR2C (0.67) | HTR2CHTR2AHTR2BPTGS2 | |
| SCHEMBL4002004 | 0.82 | HTR2C (0.62) | HTR2CHTR2AHTR2BHTR6TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117945840-A | Method and system for preparing mixed dicyclohexylbenzene | 中国石油化工股份有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-117945829-A | Method and system for preparing C18 mixed aromatic hydrocarbon | 中国石油化工股份有限公司 | 2024-04-30 | — | — | CN | disclosed |
| US-10710945-B2 | Aromatic compositions and methods for obtaining them | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-07-14 | — | — | US | disclosed |
| US-20180237361-A1 | Aromatic Compositions and Methods for Obtaining Them | EXXONMOBIL CHEMICAL PATENTS INC. | 2018-08-23 | — | — | US | disclosed |
| WO-2017052790-A1 | AROMATIC COMPOSITIONS AND METHODS FOR OBTAINING THEM | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-03-30 | — | — | WO | disclosed |
| US-20050215433-A1 | Aromatic fluid as agricultural solvent | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180237361-A1 | Aromatic Compositions and Methods for Obtaining Them | AHR, ARNT, TDO2 | HTR2C 1544/4885HTR2A 1090/4885HTR2B 861/4885 |
| US-10710945-B2 | Aromatic compositions and methods for obtaining them | AHR, ARNT, TDO2 | HTR2C 1544/4885HTR2A 1090/4885HTR2B 861/4885 |
| US-20050215433-A1 | Aromatic fluid as agricultural solvent | DDT, AHR, ALB | HTR2C 3350/4885HTR2A 3471/4885HTR2B 3510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.